---
title: 'Hims & Hers — company profile'
canonical: 'https://feeny.ai/companies/hims-hers'
type: 'company'
updated: '2026-07-02'
---

# Hims & Hers

> Digital health platform connecting people to licensed providers for personalized, cash-pay treatment across sexual health, weight loss, hair, mental health and dermatology.

- **Website:** https://www.hims.com
- **Type:** Public (NYSE: HIMS)
- **Headquarters:** San Francisco, California, USA
- **Founded:** 2017
- **Founders:** Andrew Dudum, Jack Abraham, Hilary Coles
- **Valuation:** Public; ~$1.6B at 2021 SPAC debut (market cap now moves with the stock)
- **Total raised:** ~$260M private before going public
- **Latest round:** Public via SPAC (Oaktree Acquisition Corp.), January 2021, at a $1.6B valuation
- **Investors:** Oaktree Capital, Maverick, IVP
- **Business model:** Recurring, cash-pay subscriptions for ongoing provider access and Care Team support, with prescribed medication billed on top; no insurance in the loop. Owned pharmacy and fulfillment keep margins in-house.
- **Industries:** Healthcare IT
- **Open roles:** 77
- **Profile:** https://feeny.ai/companies/hims-hers

## What they do

A direct-to-consumer telehealth platform: users complete an online intake, a licensed provider in their state reviews it asynchronously, and prescribed treatment ships on a recurring subscription with 24/7 Care Team access via the app.

## Overview

**The telehealth brand that turned awkward problems into a $2B business**

Hims & Hers built a company on the stuff people are too embarrassed to bring to their doctor. Hair loss, erectile dysfunction, anxiety, weight, low testosterone: fill out a form, get seen by a licensed provider in your state, and the treatment ships to your door in a plain box. Andrew Dudum started it in 2017, took it public through an Oaktree SPAC in early 2021 at a $1.6B valuation, and it now trades on the NYSE under HIMS.

The model has scaled hard. Revenue hit roughly $2.35 billion in 2025, up about 59% year over year, with more than 2.5 million subscribers and, unusually for a growth-stage consumer health name, actual net income. The next act is weight loss, where GLP-1 drugs like Wegovy have become both the biggest tailwind and the biggest source of drama.

## What They Do

**Skip the waiting room, keep the prescription**

Hims & Hers is a direct-to-consumer telehealth platform. You answer questions about your symptoms and history, a licensed provider in your state reviews the intake asynchronously (usually within hours, no video required for most conditions), and if a treatment is appropriate it gets prescribed and shipped on a recurring subscription. A Care Team stays reachable 24/7 through the app at no extra cost.

The two brands split by audience. Hims covers men's sexual health, hair, mental health, testosterone and weight; Hers covers women's health, birth control, skincare, hair, mental health and weight. Underneath both sits the same machine: intake, provider network, affiliated pharmacies, and fulfillment. Care does not run through insurance, which keeps it simple and cash-pay but also caps who it works for.

## Problems

**Care for the conditions people won't say out loud**

The pitch is friction removal. Traditional care for ED, hair loss, or anxiety means a scheduled visit, an awkward conversation, a pharmacy trip, and often insurance friction, which is exactly why a lot of people never bother. Hims & Hers replaces that with a ten-minute online assessment, a provider review measured in hours, and discreet delivery.

The second problem it attacks is stigma itself. A big chunk of the brand's spend goes to normalizing conversations most healthcare marketing avoids, which is what lets it acquire customers cheaply in categories legacy providers underserve.

### Problems addressed

- Friction and stigma around care for common conditions (ED, hair loss, mental health, weight)
- Slow, insurance-gated access to routine prescriptions
- Lack of ongoing, convenient provider support between visits

## Who It's For

**Built for the cash-pay consumer who wants care without the hassle**

The customer is an individual, not a clinic or an employer. It skews toward people who want convenient, private, cash-pay access for common chronic or lifestyle conditions and who are comfortable managing care over chat instead of face to face. Reviewers consistently flag the same fit: it works well for someone refilling or maintaining a known treatment, and less well for anyone who needs intensive, hands-on clinical oversight.

### Ideal customer profiles

- **Discreet-care seeker** — Embarrassment or friction getting seen for stigmatized conditions; Wants private, at-home treatment
- **GLP-1 weight loss customer** — Wants accessible, supported GLP-1 access without a specialist referral
- **Maintenance patient** — Needs low-hassle refills and ongoing support for a known treatment

## Products

**Two brands, one platform, and a lab-testing land grab**

The product line is organized around conditions rather than a single app. Sexual health and hair were the wedge; mental health, weight loss and testosterone are the growth engines now, with at-home lab testing (130+ biomarkers) pushing the company upstream into preventive, longitudinal care.

The quieter differentiator is MedMatch, the company's own recommendation layer that mines de-identified data across millions of interactions to help providers pick treatments. With 2.5 million subscribers feeding it, the data advantage compounds the longer the company runs.

## Business Model

**Recurring subscriptions, cash-pay, medication billed on top**

Hims & Hers makes money on recurring subscriptions, not one-off visits. You pay a membership for ongoing access to a provider and Care Team, and prescribed medication is billed on top. Weight loss shows the shape clearly: the membership runs $39 for the first month then $149/month, with GLP-1 medication like Wegovy priced separately if prescribed.

There is no insurance in the loop, which keeps pricing transparent and margins in the company's control, and it is why the business could turn a profit at scale where insurance-dependent telehealth peers struggled.

### Plans

Cash-pay recurring subscriptions rather than per-visit billing. A membership covers ongoing provider access and Care Team support; prescribed medication is billed separately on top. Weight loss is the clearest published example. No insurance is accepted.

- **Weight Loss Membership** — $39 first month, then $149/month · Consumers pursuing GLP-1-based weight loss
  24/7 provider access and personalized support; medication billed separately if prescribed
  - 24/7 provider and Care Team access
  - Personalized support and coaching
  - Access to GLP-1 lineup if prescribed
  - Medication (e.g. Wegovy) priced separately

Good to know: Medication cost is not included in the membership and is only available if prescribed; No insurance accepted; cash-pay; Compounded products are not FDA-approved for safety, effectiveness or quality

## Competition

**Ro, Teladoc, and the pharmacies now selling GLP-1s direct**

Hims & Hers sits in a crowded telehealth field against Ro, Teladoc, and a wave of DTC pharmacy plays, plus category specialists in hair (Keeps) and weight. Its edge is brand: it spends to own the cultural conversation around stigmatized conditions and converts that attention into cheap, recurring subscribers, then reinforces it with an owned pharmacy-and-fulfillment stack and the MedMatch data moat.

The live threat is upstream. When drugmakers like Novo Nordisk decide who gets to sell their GLP-1s and on what terms, a distribution-and-brand company is exposed to the manufacturer's mood, as the 2025 blow-up showed.

### Their edge

- **Brand-led acquisition** — Spends to own the cultural conversation around stigmatized conditions, converting attention into cheap, recurring subscribers.
- **Owned pharmacy and fulfillment** — Affiliated pharmacies and in-house fulfillment control the discreet delivery experience end to end.
- **MedMatch data moat** — Millions of de-identified interactions across 2.5M+ subscribers feed a recommendation layer that improves with scale.
- **Profitable cash-pay model** — Reaches profitability without insurance, unlike many insurance-dependent telehealth peers.

### Where they're betting

- GLP-1 weight loss and metabolic health
- At-home labs and preventive/longitudinal care
- International expansion (UK, Europe)
- Deepening the MedMatch data advantage

## Proof

**The numbers behind the growth story**

The traction is real and public. Roughly $2.35 billion in 2025 revenue, up about 59%, more than 2.5 million subscribers, $128 million of net income, and $318 million of adjusted EBITDA. Management guided 2026 revenue to $2.7B to $2.9B. For a consumer health company that was a niche ED brand seven years ago, that is a fast climb, and the profitability is the part that separates it from most of digital health.

## What People Say

**Loved for convenience, dinged on billing and thin oversight**

The recurring praise is speed and ease: a ten-minute intake, a provider review often inside twelve hours, free discreet shipping, and ongoing chat support that makes refills painless. That is the whole reason people pick it.

The recurring complaints cluster around two things. Billing and cancellation come up again and again, with customers reporting surprise charges and hard-to-reverse refunds. And the asynchronous, chat-only model that makes it convenient also means no face-to-face provider contact, which reviewers say leaves gaps for anyone new to a medication or needing closer care.

## Funding

**From a $260M private run to a $1.6B public debut**

As a private company Hims & Hers raised around $260 million from Oaktree Capital, Maverick, IVP and others before choosing the public markets over another round. In January 2021 it merged with Oaktree Acquisition Corp., a SPAC, at a $1.6 billion valuation and began trading as HIMS. Everything since has been a public-company story, so the market cap now moves with the stock rather than a funding round.

## Team & Culture

**Remote-first across the US, with a clinical spine**

The company runs talent-first and flexible, with employees spread across dozens of US states and a stated work-from-anywhere-in-the-US posture for many roles. Culture signals from the careers materials lean fun and mission-driven, with monthly all-hands, executive fireside chats and interest-based Slack channels.

One thing to know before applying: this is not a pure software shop. Alongside the engineering and product teams there is a heavy regulated-operations side (compounding pharmacists, sterile-compounding process engineers, lab and environmental-monitoring staff in Arizona and Ohio), so the org spans a Silicon Valley product culture and an FDA-regulated manufacturing floor.

## Compensation

**Equity, ESPP, and unlimited PTO on top of base**

Disclosed base ranges span the org, from hourly pharmacy and lab operations roles into six figures for engineering, product, design and marketing, with the widest engineering bands running into the low-to-mid $300Ks for senior and staff levels. Ranges also appear in GBP, EUR and CAD, reflecting the UK, Europe and Canada footprint.

The package is more than base. Roles advertise equity, an Employee Stock Purchase Program, 401(k) with employer match, unlimited PTO plus quarterly mental health days, and full medical, dental, vision and parental leave.

## Security & Legal

**The HIPAA question a lot of customers get wrong**

The registered entity is Hims & Hers Health, Inc., at 2269 Chestnut Street, #523, San Francisco, CA 94123. The privacy policy is blunt about a detail most people assume the other way: Hims & Hers itself is not a HIPAA covered entity. The affiliated Labs, Pharmacies and Medical Groups may be, and Hims & Hers may act as a business associate in some cases, but the platform's basic account data is not treated as protected health information.

The service is US-only and gated to adults, with a narrow exception for teens seeking acne treatment with guardian consent.

## In the News

**The Novo Nordisk saga defined the last year**

Weight loss made Hims & Hers a market darling and then a cautionary tale in the space of a year. It struck a Wegovy collaboration with Novo Nordisk in April 2025, Novo publicly terminated it that summer over compounding and marketing disputes, and the two sides then patched things up with a new GLP-1 deal in March 2026. For a company whose whole model depends on distributing other people's drugs, the arc is the clearest read yet on where its leverage starts and stops.

### Coverage

- [Novo, Hims reach deal to sell GLP-1 drugs together](https://www.biopharmadive.com/news/hims-novo-deal-obesity-drugs-wegovy-ozempic/814160/) — BioPharma Dive (2026-03-09)
- [Novo Nordisk's Termination of Hims & Hers Deal Reignites Compounding Row](https://www.biospace.com/business/novo-nordisks-termination-of-hims-hers-deal-reignites-compounding-row) — BioSpace (2025-07-09)
- [Digital Health Startup Hims & Hers Goes Public In $1.6 Billion SPAC Deal](https://www.forbes.com/sites/katiejennings/2021/01/20/digital-health-startup-hims--hers-goes-public-in-16-billion-spac-deal/) — Forbes (2021-01-20)
- [Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results](https://investors.hims.com/news/news-details/2026/Hims--Hers-Health-Inc--Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results/default.aspx) — Hims & Hers Investor Relations (2026-02-01)

## Outlook

**Profitable and growing, but leaning on GLP-1s and one big supplier**

Hims & Hers enters 2026 in a strong spot: profitable, growing fast, guiding to $2.7B to $2.9B in revenue, and expanding into labs, preventive health and international markets. The bet that turned awkward problems into recurring revenue clearly worked.

The watch items are just as clear. A lot of the growth now rides on GLP-1 weight loss, and the Novo Nordisk breakup and makeup showed how much of that depends on a manufacturer's goodwill and the regulatory line on compounding. The moat is brand, data and fulfillment; the risk is that it does not own the molecules everyone wants.

## Company details

- **Mission:** To help the world feel great through the power of better health.
- **Products:** Hims (men's health), Hers (women's health), Weight loss, Mental health, At-home labs, MedMatch
- **Customer segments:** Individual consumers (B2C), Cash-pay patients seeking convenient, private care for common chronic and lifestyle conditions
- **Buyers / users:** Adults seeking discreet care for stigmatized conditions (ED, hair loss, mental health), Consumers wanting cash-pay GLP-1 weight loss access, People maintaining or refilling a known treatment who prefer chat-based care
- **Competitors:** Ro, Teladoc, Keeps, GoodRx (DTC pharmacy), Amazon Pharmacy / One Medical
- **What sets them apart:** Brand-led, low-cost acquisition in stigmatized categories; Owned pharmacy and fulfillment stack; MedMatch data moat from millions of de-identified interactions; Asynchronous, cash-pay model that reaches profitability without insurance
- **Tech stack:** Asynchronous telehealth platform, Owned pharmacy and fulfillment, MedMatch AI recommendations, Electronic medical record

## Open roles (77)

- [Inventory Clerk](https://jobs.ashbyhq.com/hims-and-hers/08a43c59-40e9-46ba-b45a-9838a2de82b6) — Mesa, AZ
- [Site Leader/ Operations Director - Peptide API](https://jobs.ashbyhq.com/hims-and-hers/45562da5-db4d-47bd-83ba-53a4efe10c2f) — Menlo Park, CA
- [Compounding Lab Manager (Night Shift)](https://jobs.ashbyhq.com/hims-and-hers/f287f840-a958-4614-92a6-d7dbab6e4acc) — New Albany, OH
- [Learning Lead, Non Sterile Compounding](https://jobs.ashbyhq.com/hims-and-hers/b00a5137-e3ba-4585-95e6-2a1581625305) — Gilbert, AZ
- [Operations Engineer - Peptide API](https://jobs.ashbyhq.com/hims-and-hers/f2028c9a-adc0-49aa-a25f-74e9769593fc) — Menlo Park, CA
- [Project Manager, Peptide API Operations](https://jobs.ashbyhq.com/hims-and-hers/4e6023e9-dde0-4a09-9738-d21d5a98ab72) — Menlo Park, CA
- [Sr. Manager, Partnerships Marketing](https://jobs.ashbyhq.com/hims-and-hers/6088fdf7-7e5a-4c36-b145-e83873765e90) — Remote
- [Operations Manager, Facilities Maintenance](https://jobs.ashbyhq.com/hims-and-hers/209bbc2e-f6e9-4f1a-a63e-70d075ee38c7) — Menlo Park, CA
- [Quality Control Manager, Non-Sterile](https://jobs.ashbyhq.com/hims-and-hers/8963d0c5-039c-411c-b492-1cb894460e8c) — New Albany, OH
- [Facilities Technician, HVAC](https://jobs.ashbyhq.com/hims-and-hers/97c910af-fa29-4c86-b4d4-ff9c52f7febd) — New Albany, OH
- [Director, FP&A](https://jobs.ashbyhq.com/hims-and-hers/bd77c838-c81b-43db-8312-c9cbd4913a46) — Remote
- [Talent Acquisition Recruiter, Operations- AZ Hybrid](https://jobs.ashbyhq.com/hims-and-hers/096a50f7-b18a-4054-a8c7-66d9078630cf) — Gilbert, AZ
- [Quality Control Specialist (Day Shift)](https://jobs.ashbyhq.com/hims-and-hers/bc11fa4d-b1b8-4dc9-ba0f-e0b619cfb80a) — Gilbert, AZ
- [Analyste – Opérations et soutien / Operations & Support Analyst](https://jobs.ashbyhq.com/hims-and-hers/78fd9b8d-28cd-48b2-bc35-7caadd5191da) — Montréal, Canada
- [Lead Product Manager, Consumer Apps](https://jobs.ashbyhq.com/hims-and-hers/e809a108-e72b-45c1-b2c4-aad645a00772) — Remote
- [Sr. Platform Engineer](https://jobs.ashbyhq.com/hims-and-hers/03409df3-5d56-4cb0-9c33-8c28832d0ed0) — Remote
- [Quality Control Specialist (Night Shift)](https://jobs.ashbyhq.com/hims-and-hers/ae27778e-3eaa-436b-880f-1cb37466cb7a) — Gilbert, AZ
- [Manager, Legal Operations](https://jobs.ashbyhq.com/hims-and-hers/257817b3-b7d6-4ed9-86c6-7c76c57a17f8) — Remote
- [Analytical Chemist, R&D](https://jobs.ashbyhq.com/hims-and-hers/572da76a-45c2-4092-8fce-bb603b5bd96c) — New Albany, OH
- [Talent Acquisition Specialist, Operations- AZ Hybrid](https://jobs.ashbyhq.com/hims-and-hers/ba9dc5f4-23a4-439c-bd58-2f66e6f6f29c) — Gilbert, AZ
- [Compounding Pharmacy Technician (Days)](https://jobs.ashbyhq.com/hims-and-hers/4e550979-c23e-45fd-b971-07278db9c196) — Gilbert, AZ
- [Compounding Pharmacist (Nights)](https://jobs.ashbyhq.com/hims-and-hers/c882539e-7b56-40c9-9f76-e0f5bbc76aa6) — Gilbert, AZ
- [Director, Engineering - Commerce](https://jobs.ashbyhq.com/hims-and-hers/ac87ad52-2fe3-4f14-b52f-b61bf065e669) — Remote
- [Compounding Pharmacy Technician (Nights)](https://jobs.ashbyhq.com/hims-and-hers/04d538b7-05aa-4786-b5e9-828e469645b4) — Gilbert, AZ
- [Staff Engineer, AI-Assisted Engineering Practices](https://jobs.ashbyhq.com/hims-and-hers/b304b361-8d07-4715-b07e-789ac6a121ce) — Remote
- [Staff Machine Learning Systems Engineer (MLOps)](https://jobs.ashbyhq.com/hims-and-hers/57cd17f4-c58b-4a4c-a423-b7ad2e0b7aed) — United States
- [Senior Financial Analyst, Ops Finance](https://jobs.ashbyhq.com/hims-and-hers/ced4fc17-0e81-436c-a921-ab44ab656dac) — Remote
- [Head of/Director, International Regulatory Affairs](https://jobs.ashbyhq.com/hims-and-hers/b1c65b91-9e30-436c-84cd-7483ab8312bc) — London, United Kingdom
- [Staff Software Engineer, AI & Recommendations Platform](https://jobs.ashbyhq.com/hims-and-hers/cb2005a0-d77c-44ad-8721-bff67d45fe0d) — Remote
- [Quality Control Specialist, Sterile (Night Shift)](https://jobs.ashbyhq.com/hims-and-hers/4fed4f1d-fdfa-4617-9af4-f013446f6a6e) — New Albany, OH
- [Lead Product Manager](https://jobs.ashbyhq.com/hims-and-hers/67ee2d18-aa50-45cb-9dbf-787184aaabab) — Remote
- [Lead, Pharmacy Technician](https://jobs.ashbyhq.com/hims-and-hers/c42a5d80-46f9-4be8-a62c-eb6d498d0d11) — New Albany, OH
- [Director, Product Communications (Hers)](https://jobs.ashbyhq.com/hims-and-hers/3f801346-9b06-4333-ba34-e7bc09454c3d) — Remote
- [Counsel, Privacy & AI](https://jobs.ashbyhq.com/hims-and-hers/3595fd6a-a10f-4ccf-b791-8cb015ee66fe) — Remote
- [Compounding Pharmacist (Wed-Sat Days)](https://jobs.ashbyhq.com/hims-and-hers/24738cca-b1e9-4593-bba2-8aae13e9d9c0) — Gilbert, AZ
- [Environmental Monitoring (EM) Specialist](https://jobs.ashbyhq.com/hims-and-hers/f5d6d49b-a690-4e49-8f53-d3859e92955a) — Gilbert, AZ
- [Operations Manager (Nights)](https://jobs.ashbyhq.com/hims-and-hers/81e96ac3-1487-4f6e-81cc-f94f8da5fa0d) — Gilbert, AZ
- [Sr. Program Manager, Inventory Control - Pharmacy](https://jobs.ashbyhq.com/hims-and-hers/8f38faa1-17db-4de8-a367-8c911faf8fe8) — Gilbert, AZ
- [Senior Quality Control, Gummy Specialist](https://jobs.ashbyhq.com/hims-and-hers/256fc252-af87-4614-bad2-d949b40b1eb7) — Gilbert, AZ
- [Sr. Producer](https://jobs.ashbyhq.com/hims-and-hers/63d3600d-37ef-4e26-a075-bb2cbb6bcafa) — Remote
- [Counsel, Production](https://jobs.ashbyhq.com/hims-and-hers/32753be8-bdad-498c-b2da-b814c6c0a976) — Remote
- [Head of/Director, Government Affairs - UK & EU](https://jobs.ashbyhq.com/hims-and-hers/6b7230c2-f486-456b-a970-27fd0d8c78d2) — London, United Kingdom
- [Talent Acquistion Lead, Operations- AZ Hybrid](https://jobs.ashbyhq.com/hims-and-hers/3cbc5853-0989-4fd8-bc92-6dbfbcb448da) — Gilbert, AZ
- [Sr. Manager, Non-Sterile Compounding Operations](https://jobs.ashbyhq.com/hims-and-hers/94bb6aa2-9846-4749-af12-efbc6e6a1134) — Mesa, AZ
- [Staff Software Engineer, Growth](https://jobs.ashbyhq.com/hims-and-hers/5ff1f5e3-e6f4-4947-8ef3-fe40abe1fa6c) — Remote
- [Senior Manager, Quality Systems](https://jobs.ashbyhq.com/hims-and-hers/5b589a44-309b-423e-8841-cb8f7b1742b5) — Los Alamitos, CA
- [Sr. Digital Designer, Contract](https://jobs.ashbyhq.com/hims-and-hers/2ee142a7-c3fe-4fc1-84dd-11a72f304344) — Remote
- [Maintenance Tech II, Compounding Facilities](https://jobs.ashbyhq.com/hims-and-hers/9178db83-264f-418b-805b-9f83198cc6c7) — New Albany, OH
- [Director, Regulated Diagnostics Lab](https://jobs.ashbyhq.com/hims-and-hers/cc555f05-d531-4101-a086-649ef72fed4a) — South Plainfield, NJ
- [Specialist, Workplace Health & Safety (WHS)](https://jobs.ashbyhq.com/hims-and-hers/59cb89e2-3ba6-41d3-b560-749abe0f9e18) — Gilbert, AZ

_…and 27 more at https://feeny.ai/companies/hims-hers/jobs_

---
_Source: https://feeny.ai/companies/hims-hers · profile updated 2026-07-02_